C
CRMD
Cormedix
7.54
-0.60-7.37%After Hours: 7.57 +0.03 +0.40%19:34 08/14 EDT
OPEN/PREV CLOSE8.29/8.23
TODAY RANGE8.16-8.41
VOL1.50M
MARKET CAP639.14M
52 WEEK RANGE6.13-14.96
AVG VOL (3M)1.32M
% TURNOVER1.92%
TURNOVER--
P/E (TTM)3.849
% RANGE3.10%
EPS(TTM)2.131
P/E(FORWARD)16.08
P/B1.382
BVPS5.93
DIVIDEND--
P/S2.085
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP590.71M
SHARES OUTSTANDING77.94M
NEXT EARNINGS11/10-11/16
FREE FLOAT72.04M
LOT SIZE1
EX-DATE03/26/2019
News
Press Releases
Financial Reports
Profile
TipRanks·22h ago
Cormedix Inc. Earnings Call Signals Strong Growth
Seeking Alpha·3d ago
CorMedix: Durable Commercial Base, But 2027 Is The Real Test
Dow Jones·08/14 15:36
CorMedix Is Maintained at Outperform by RBC Capital
TipRanks·08/14 12:36
RBC Capital Sticks to Their Buy Rating for Cormedix (CRMD)
Seeking Alpha·08/13 17:14
CorMedix shares jump 15% after Q2 earnings beat
Benzinga·08/13 14:56
CorMedix Stock Jumps on Strong DefenCath Sales
Benzinga·08/13 13:57
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday
Benzinga·08/13 13:07
Full Transcript: Cormedix Q2 2026 Earnings Call
NASDAQ·08/13 12:45
CorMedix (CRMD) Q2 Earnings and Revenues Top Estimates
Dow Jones·08/13 11:45
*CorMedix Raises FY Adj EBITDA Guidance to $125 M to $140 M >CRMD
Dow Jones·08/13 11:45
*CorMedix FY Cash OpEx Guidance Is Narrowed to $145 M to $155 M >CRMD
Dow Jones·08/13 11:44
*CorMedix Backs FY26 Rev $325M-$345M >CRMD
Seeking Alpha·08/13 11:34
CorMedix rises after reporting Q3 results
Same Industry
Name/Symbol
Change%
Price